Insulin pump therapy in childhood diabetes—cost implications for Primary Care Trusts

Abstract

The additional resources required to pay for insulin pump therapy for a small proportion of the diabetes population would be minimal given the potential benefits to these patients of improved control and anticipated reduction in long-term morbidity.